746 related articles for article (PubMed ID: 32615937)
1. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
2.
Hashiba Y; Umekita K; Minami H; Kawano A; Nagayasu E; Maruyama H; Hidaka T; Okayama A
Mod Rheumatol Case Rep; 2021 Jan; 5(1):16-21. PubMed ID: 32772699
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
Stewart DM; Ramanathan R; Mahanty S; Fedorko DP; Janik JE; Morris JC
Acta Haematol; 2011; 126(2):63-7. PubMed ID: 21474923
[TBL] [Abstract][Full Text] [Related]
4. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
5. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
6. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
[TBL] [Abstract][Full Text] [Related]
7. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
8. Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia.
Alpern JD; Arbefeville SS; Vercellotti G; Ferrieri P; Green JS
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860061
[TBL] [Abstract][Full Text] [Related]
9. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
10. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
11. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
13. Strongyloides hyperinfection syndrome and cytomegalovirus infection in a patient with type II diabetes mellitus.
Wang Z; Guo J; Liu J
New Microbiol; 2023 Feb; 46(1):86-89. PubMed ID: 36853825
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
15. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
16. Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus.
Yung EE; Lee CM; Boys J; Grabo DJ; Buxbaum JL; Chandrasoma PT
Am J Trop Med Hyg; 2014 Oct; 91(4):806-9. PubMed ID: 25092815
[TBL] [Abstract][Full Text] [Related]
17. Duodenal obstruction due to
Harshan M; Niyas VKM; Arjun R
Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
[No Abstract] [Full Text] [Related]
18. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
Lambertucci JR; Leão FC; Barbosa AJ
Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
[No Abstract] [Full Text] [Related]
19. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
20. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
Choksi TT; Madison G; Dar T; Asif M; Fleming K; Clarke L; Danilewitz M; Hennawy R
Am J Trop Med Hyg; 2016 Oct; 95(4):864-867. PubMed ID: 27527631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
